Communiqués Pacific Biosciences of California, Inc. BOERSE MUENCHEN

Actions

P09

US69404D1081

Equipement et technologie médicale avancés

Marché Fermé - BOERSE MUENCHEN Autres places de cotation 22:43:53 07/08/2026			Varia. 5j.	Varia. 1 janv.
1,026 ^EUR	+1,58%		-15,97%	-30,68%

05/08	Transcript : Pacific Biosciences of California, Inc., Q2 2026 Earnings Call, Aug 05, 2026
05/08	Pacific Biosciences annonce un plan de restructuration et réduit ses effectifs de 8 % pour viser jusqu'à 40 millions de dollars d'économies annuelles d'ici 2027	CI

Communiqués

05/08	Pacific Biosciences: Q2 Earnings Snapshot	AQ
05/08	PacBio Announces Second Quarter 2026 Financial Results	AQ
05/08	PacBio Appoints Mark Van Oene as President and Chief Executive Officer	AQ
05/08	PacBio Announces Faster Runs, Up to 50% More HiFi Data, and New Compliance Controls for the Vega system	AQ
28/07	PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference	AQ
15/07	PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026	AQ
26/05	PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing	AQ
21/05	PacBio to Participate in the Jefferies Global Healthcare Conference	AQ
19/05	Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology	BU
12/05	Pacific Biosciences of California : PacBio1Q26 Prepared Remarks	PU
11/05	HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss	AQ
08/05	Pacific Biosciences of California : PacBio Q1 2026 Earnings Presentation	PU
07/05	Pacific Biosciences: Q1 Earnings Snapshot	AQ
07/05	PacBio Announces First Quarter 2026 Financial Results	AQ
24/04	Pacific Biosciences of California : ' 2026 Proxy Statement	PU
24/04	Pacific Biosciences of California : ' 2025 Annual Report	PU
21/04	PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing	AQ
16/04	PacBio to Report First Quarter 2026 Financial Results on May 7, 2026	AQ
16/04	PacBio and Covaris Announce Joint Workflow Enabling HiFi Sequencing of FFPE Tumor Samples	AQ
15/04	PacBio and Covaris Announce Joint Workflow Enabling HiFi Long-Read Sequencing of FFPE Tumor Samples	AQ
08/04	Ontario-Based DNAstack Leads Sovereign AI for Genomics and Health with Goal of Making Canadians Healthier and Reducing Strain on our Healthcare System	AQ
18/03	Pacific Biosciences of California : Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative	PU
18/03	Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative	AQ
05/03	PacBio Announces the Appointment of Chris Gibson to the Board of Directors	AQ
24/02	PacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease Research	AQ